ONCOSELECT AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−30k kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−2k kr).

ONCOSELECT AS is registered as a limited company in Oslo, Oslo with organisation number 820312872. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2017. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Utvikle og markedsføre produkter og tjenester innen biomedisin, herunder konsulentvirksomhet, forskningstjenester og investeringer i egenutviklede produkter eller lisenser relatert til diagnostikk og behandling, samt deltakelse i andre selskaper.”. The most recent filed accounts, for the 2024 financial year, show NOK 0 in revenue and NOK −2,000 in operating profit.

Key figures · 2024

Revenue

NOK 0

Operating profit

NOK −2,000

Equity

NOK −30,000

Financial health · 2024

Liquidity

0.00

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-42058.3%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns ONCOSELECT AS?

FAHRI SAATCIOGLU

100.0%

ONCOSELECT AS

NOK 0 rev. · NOK −2,000 profit

ONCOSELECT AS has 1 registered shareholder:

• FAHRI SAATCIOGLU 100.0%

All shareholders and roles →

Frequently asked questions about ONCOSELECT AS

Who owns ONCOSELECT AS?

FAHRI SAATCIOGLU is the largest registered owner, with 100.0%.

What is the revenue of ONCOSELECT AS?

ONCOSELECT AS had revenue of NOK 0 in 2024.

Who is the general manager of ONCOSELECT AS?

Fahri Saatcioglu is registered as general manager of ONCOSELECT AS.

Where is ONCOSELECT AS based?

ONCOSELECT AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.